A phase I, first-in-human, open-label, dose escalation and expansion study of PT886 in adult patients with advanced gastric, gastroesophageal junction, and pancreatic adenocarcinom... von Overman, Michael J., Melhem, Ramzi, Blum-Murphy, Mariela A., Ramos, Claudia, Petrosyan, Lina, Li, Jack, Perer, Jessica K, Zou, Hui, Wang, Ming, Wright, Harold M

Volltext